Showing results (131-140 of 1,803) with videos related to
Sort By:
Pageof 181
Transplantation and Cellular Therapy|September 24, 2021
American Society for Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantationMichelle K Yong, Terri Lynn Shigle, Yae-Jean Kim, et al.Transplantation and Cellular Therapy|February 10, 2022
Calprotectin Expressing Donor-Derived Macrophages Increase in Acute Gastrointestinal Graft-Versus-Host DiseaseAnders Theodor Aasebo, Tobias Gedde-Dahl, Henrik Mikael Reims, et al.Transplantation and Cellular Therapy|January 22, 2022
Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell TransplantationTim Bognàr, Imke H Bartelink, Toine C G Egberts, et al.Transplantation and Cellular Therapy|January 23, 2022
Post-Transplantation Multicolored Flow Cytometry-Minimal Residual Disease Status on Day 100 Predicts Outcomes for Patients With Refractory Acute Myeloid LeukemiaEvgeny Klyuchnikov, Anita Badbaran, Radwan Massoud, et al.Transplantation and Cellular Therapy|February 5, 2022
Real-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based AnalysisRobert Puckrin, Douglas A Stewart, Mona ShafeyTransplantation and Cellular Therapy|February 5, 2022
Impact of Human T Cell Lymphotropic Virus Type 1 and 2 Infection on Survival Following Stem Cell TransplantationVishal K Gupta, Areej El-Jawahri, Grigori Orkev, et al.Transplantation and Cellular Therapy|January 25, 2022
Optimal Timing of Allogeneic Stem Cell Transplantation for Primary MyelofibrosisChristopher Cipkar, Srishti Kumar, Kednapa Thavorn, et al.Transplantation and Cellular Therapy|March 17, 2022
High Mortality of COVID-19 Early after Allogeneic Stem Cell Transplantation: A Retrospective Multicenter Analysis on Behalf of the German Cooperative Transplant Study GroupJudith Schaffrath, Christina Brummer, Daniel Wolff, et al.Transplantation and Cellular Therapy|March 22, 2022
Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell TransplantationHaiTao Wang, YingXin Zhao, Shu Fang, et al.Transplantation and Cellular Therapy|October 14, 2021
Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 InfectionNishi Shah, Parastoo B Dahi, Doris M Ponce, et al.Pageof 181